Investment Rating - The investment rating for Li Ning has been upgraded from "Neutral" to "Buy" by UBS [1] Core Insights - UBS expects a significant acceleration in sales growth for the first quarter of this year, shifting from a low single-digit decline to a mid-to-high single-digit increase, driven primarily by the Glory series, new outdoor categories, as well as strong performance in badminton and running shoe products [1] - The net profit forecasts for 2025 to 2027 have been raised by 4% to 7%, with the target price increased from HKD 21.8 to HKD 28.6, which corresponds to a projected price-to-earnings ratio of 18 times for 2027 [1] - UBS projects the earnings per share for Li Ning from 2026 to 2029 to be RMB 1.18, 1.37, 1.55, and 1.7 respectively [1]

Investment Rating - The report assigns a "Neutral" rating to HSBC Holdings [1] Core Insights - HSBC's Q4 performance exceeded market expectations, with pre-tax profit excluding significant items 9% higher than anticipated, revenue 3% above expectations, and net interest income 6% higher (5% excluding one-off items) [1] - Fee and other income fell short of expectations by 1%, while operating expenses met forecasts, and credit impairment was 12% lower than market predictions [1] - The Common Equity Tier 1 (CET1) capital ratio stood at 14.9%, surpassing market expectations, and the adjusted CET1 ratio, accounting for the privatization of Hang Seng, was 13.8% [1] Financial Projections - The net cost impact of the acquisition of Hang Seng on the CET1 capital ratio is confirmed to be 110 basis points, which is better than expected, with projected benefits of $900 million by FY2028 and restructuring costs of $600 million [1] - The transaction is deemed significant for increasing HSBC's exposure to the Hong Kong banking sector and simplifying the group's structure [1] - HSBC declared a fourth-quarter dividend of $0.45 per share and continues to suspend share buybacks, aligning with market expectations, while management provided new guidance for FY2026 [1]

香港交易所(00388):上季盈利强劲,维持"增持"评级 摩根大通 摩根大通发布研报称，香港交易所(415.4,3.20,0.78%)(00388)公布2025年第四季净利润43亿港元，按季 下跌12%，同比增长15%，较该行预期高出19%。该行预期股价将走强，维持对港交所的"增持"评级，目标价 540港元。 2025财年全年纯利178亿港元，同比升36%，较市场预期高2%。业绩优于预期主要受收入带动。交易及结算 费收入按季跌幅(-14%/-16%)较该行预期温和，尽管成交量呈季节性疲弱(现货股票日均成交额按季跌21%)。此 等收入抵销了表现逊于预期的托管费及市场数据费。盈利受惠于非上市股权投资估值录得1.63亿港元非经常性 收益，以及港交所企业资金回报提升，足以抵销自去年10月起向市场参与者调整旗下结算所向其参与者支付的 现金抵押品利息的计算方法，并下调对非现金抵押品的融通费用的影响。上述因素带动净投资收益表现强劲 (12亿港元，按季升20%)，成为业绩优于预期的主要原因。值得留意的是，即使撇除1.63亿港元收益，除税前 利润50亿港元仍录得同比16%增长，较该行预测高出15%。成本管控符合预期，总开支同比 ...

Investment Rating - The report maintains an "Overweight" rating for HSBC Holdings with a target price of HKD 165 [1] Core Insights - HSBC's fourth-quarter revenue and underlying pre-tax profit exceeded market expectations by 3% and 9% respectively, with a Common Equity Tier 1 (CET1) ratio of 14.9%, surpassing market expectations by 20 basis points [1] - The group has updated its return on tangible equity (ROTE) guidance for the next three years to 17% or above, which is higher than the previous mid-teens guidance and market expectations [1] - The group anticipates revenue growth of 5% by 2028, which is above both Morgan Stanley's and market expectations [1] - The quality of commercial real estate assets in Hong Kong is stabilizing, with a quarterly decrease in stage two loans and stable stage three loans [1] Additional Insights - The group aims to achieve USD 900 million in benefits by 2028 from the acquisition of Hang Seng Bank, including USD 300 million in cost savings, USD 200 million in revenue synergies, and USD 400 million in additional revenue and cost optimization [2] - This initiative is estimated to increase ROTE by approximately 40 basis points by 2028 [2]

快手-W(01024):重申"买入"评级,目标价94港元 美银美林 美银发布研报称，重申快手-W(63.6,-2.75,-4.14%)(01024)"买入"评级，予目标价94港元，认为市场对 竞争的担忧可能有些过头。 该行预计快手2025年第四季业绩将符合预期，并维持先前的预测。预期收入同比增10%至389亿元人民币 (下同)，调整后净利同比增15%至54亿元。预计广告/电商收入将同比增13%及17%。预期快手可灵(Kling)业务 第四季营收为3.7亿元，高于先前预测的3.3亿元。 ...

Investment Rating - The report assigns a "Buy" rating to WuXi XDC (02268.HK) for the first time, with a target price of HKD 80, compared to the current price of HKD 58.35 [2][11]. Core Insights - WuXi XDC is positioned to enter a commercialization phase, leveraging its end-to-end integrated CRDMO services and industry-leading technology platform to solidify its leading position in the bioconjugate drug CRDMO sector [1][15]. - The bioconjugate drug industry is experiencing rapid growth, with ADC drugs expected to reach USD 66.2 billion by 2030, and WuXi XDC projected to capture over 24% of the global ADC outsourcing market by 2025 [1][9]. Summary by Relevant Sections Company Overview - WuXi XDC is a joint venture between WuXi Biologics and Hengrui Medicine, focusing on ADC and broader bioconjugate drug markets, providing comprehensive CRDMO services [15][17]. Financial Projections - Revenue projections for WuXi XDC are as follows: - 2024: HKD 4,052 million - 2025: HKD 5,922 million (growth of 46.1%) - 2026: HKD 8,011 million (growth of 35.3%) - 2027: HKD 10,461 million (growth of 30.6%) - Net profit projections are: - 2024: HKD 1,070 million - 2025: HKD 1,481 million (growth of 38.5%) - 2026: HKD 1,989 million (growth of 34.3%) - 2027: HKD 2,600 million (growth of 30.7%) [2][11]. Industry Trends - The bioconjugate drug industry is rapidly expanding, with ADC drugs being the primary focus. The report highlights the emergence of several blockbuster ADC drugs, with six expected to exceed USD 1 billion in sales by 2025 [9][32]. - The outsourcing rate for ADC drugs is projected to remain high at approximately 60%, benefiting companies like WuXi XDC [9][29]. Technological Strengths - WuXi XDC boasts strong technical capabilities with proprietary technologies such as WuXiDARx™, X-LinC conjugation technology, and various payload conjugation platforms, enhancing its competitive edge [7][10]. Capital Expenditure and Growth Strategy - The company plans to invest HKD 1.7 billion in capital expenditures by 2026 to support its global dual-factory production strategy, enhancing its capacity for conjugated raw materials and formulations [7][10]. Market Position - WuXi XDC is expected to have a significant market share in the global ADC outsourcing market, projected to reach over 24% by 2025, reflecting its strong growth trajectory and market demand [1][9].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside of 15% to 35% [4][11]. Core Insights - The company is expected to see significant growth in HSD (High-level Driving System) in 2026, with the demand for Level 3 (L3) autonomous driving solutions anticipated to increase, suggesting a strong market opportunity [7][9]. - The company has a robust product portfolio that includes multiple solutions for mid to high-level autonomous driving, actively expanding its partnerships with automotive manufacturers [7][9]. - The report forecasts net profits for the company to reach -57.7 million RMB in 2025, -29 million RMB in 2026, 2 million RMB in 2027, and 21 million RMB in 2028, with corresponding EPS of -0.39, -0.20, 0.01, and 0.14 RMB respectively [9][10]. Summary by Sections Company Overview - The company operates in the machinery and equipment industry, with a current H-share price of 8.16 HKD as of February 26, 2026, and a market capitalization of 0 billion [3]. Recent Ratings - The last rating update was on June 24, 2025, with a closing price of 6.37 HKD and a "Buy" recommendation [4]. Financial Projections - The projected net profit for 2024 is 2,347 million RMB, with subsequent years showing a decline into losses before returning to profitability in 2027 and 2028 [10]. - Revenue from product sales is expected to grow from 2,384 million RMB in 2024 to 18,543 million RMB in 2028, indicating a strong upward trend in sales [12]. Market Trends - The report highlights that the penetration rate of vehicles equipped with urban NOA (Navigation on Autopilot) reached 15.1% in 2025, up by 5.6 percentage points from 2024, reflecting a growing acceptance of advanced driving technologies [9]. - The commercial rollout of L3 autonomous driving technology is expected to accelerate, with a projected market size for autonomous driving chips exceeding 100 billion RMB [9].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside of 15% to 35% [4][11]. Core Insights - The company is expected to see significant growth in HSD (High-level Smart Driving) in 2026, with the launch of L3 autonomous driving technology enhancing demand for smart driving solutions. The report suggests a "Buy" recommendation based on these developments [7][9]. - The company has a strong product portfolio that includes multiple solutions for mid to high-level smart driving, actively expanding its customer base among automotive manufacturers and providing development services based on its chips [7][9]. - The report anticipates a rapid increase in high-level NOA (Navigation on Autopilot) demand, projecting over 50% growth in the next two years, with the smart driving chip market expected to exceed 100 billion [9]. Financial Summary - The company’s projected net profits for 2025, 2026, 2027, and 2028 are estimated at -57.7 billion, -29.2 billion, 2 billion, and 21 billion respectively, with corresponding EPS of -0.39, -0.2, 0.01, and 0.14 [9][10]. - Revenue from product sales is expected to grow from 2.384 billion in 2024 to 18.543 billion by 2028, with a significant increase in sales costs and R&D expenses over the same period [12]. - The projected P/S ratios for 2026, 2027, and 2028 are 19, 9.7, and 6.5 respectively, indicating a favorable valuation trend as the company moves towards profitability [9][10].

Investment Rating - The report maintains a "Buy" rating for Lenovo Group [4][6] Core Insights - Lenovo Group demonstrated strong resilience in the face of supply chain challenges, achieving a record revenue of $22.204 billion for FY3Q26, representing an 18% year-over-year growth. Adjusted net profit reached $589 million, up 36% year-over-year [1][4] - All business segments reported double-digit year-over-year growth, with AI-related revenue increasing by 72%, accounting for nearly one-third of total revenue [1] - The company is expected to expand its leadership in AI PCs and benefit from the strategic restructuring of its ISG business, leading to profit recovery [4] Summary by Relevant Sections IDG (Intelligent Devices Group) - Achieved revenue of $15.8 billion in FY3Q26, a 14% year-over-year increase. The PC market share reached a historic high of 24.9% for 2025, with a quarterly market share increase of 1 percentage point to 25.2% [2] - The AI PC segment saw high double-digit revenue growth, while Motorola's smartphone business set historical highs in sales and activations [2] ISG (Infrastructure Solutions Group) - Revenue for FY3Q26 was $5.2 billion, marking a 31% year-over-year increase and a historical high. The AI server business experienced high double-digit revenue growth, with a backlog of orders amounting to $15.5 billion [3] - The company implemented a strategic restructuring, incurring a one-time restructuring cost of $285 million, which is expected to yield annual cost savings of over $200 million for the next three years [3] SSG (Solutions and Services Group) - Reported revenue of $2.7 billion in FY3Q26, an 18% year-over-year increase, achieving growth for the 19th consecutive quarter. The operating profit margin improved by 1 percentage point, exceeding 22% [3] - The growth rate in digital office and AI-related sustainable development areas is twice that of the market, contributing to sustainable revenue growth [3] Financial Forecast - Projected net profits for FY26, FY27, and FY28 are $1.757 billion, $2.011 billion, and $2.390 billion, respectively, with corresponding PE ratios of 9, 8, and 6 times [5][4]

Investment Rating - The report maintains a positive investment rating for Chow Tai Fook Enterprises (CTFS) based on its consistent performance and growth potential [3]. Core Insights - The adjusted operating profit (AOP) for the first half of the fiscal year 2026 remained stable at HKD 1.469 billion, driven primarily by the growth in Chow Tai Fook Life Insurance [3]. - The interim dividend declared is HKD 0.28 per share, reflecting a 3% year-on-year increase, which exceeds market expectations [4]. - The financial services segment saw a significant AOP growth of 19% to HKD 729 million, with new business value increasing by 39% to HKD 733 million [4]. - The report highlights the importance of the stock being included in southbound trading starting March 9, which is expected to act as a significant revaluation catalyst [4]. Summary by Sections Financial Performance - The AOP for Chow Tai Fook Enterprises increased by 3% year-on-year to HKD 2.284 billion, mainly due to the profit growth from Chow Tai Fook Life Insurance, offsetting declines in other business segments [4]. - The logistics business experienced a 14% decline in AOP to HKD 332 million, while the facilities management segment saw a 12% decrease to HKD 43 million due to reduced activities and increased depreciation costs [4]. - The construction engineering segment's AOP fell by 21% to HKD 310 million, attributed to margin pressures and a prior year's one-time provision reversal [4]. Business Segments - Financial Services: AOP increased by 19% to HKD 729 million, with a 39% rise in new business value [4]. - Road Business: AOP slightly increased by 1% to HKD 771 million, despite a 1% decline in traffic usage and toll revenue [4]. - Logistics: AOP decreased by 14% to HKD 332 million due to reduced contributions from logistics centers [4]. - Facilities Management: AOP fell by 12% to HKD 43 million due to activity reductions and higher depreciation [4]. - Construction Engineering: AOP decreased by 21% to HKD 310 million, impacted by margin pressures [4]. Market Position - Chow Tai Fook Enterprises has a market capitalization of USD 5.48 billion, with a stock price of HKD 9.39 as of February 25, 2026 [11][15]. - The company is primarily owned by Chow Tai Fook (Holdings) Limited, holding 75.53% of the shares [11].